NICE’s EVA Pilot

NICE is the UK’s HTA body. It produces guidance on the use of pharmaceutical and medtech products within England’s NHS. Its recommendations are also often adopted in Wales and Northern Ireland.

Its EVA scheme will see 10 topics piloted in 2022/23, with mental health apps and cardiovascular and cancer diagnostic analysis products that use artificial intelligence high on the agenda (Also see "With A New Director Elect, NICE Is On A Mission To Elevate Medtech" - Medtech Insight, 29 Apr, 2022.)

NICE has said that the project aims to enable patient access to innovative products while further data are collected for use in a full clinical and cost-effectiveness evaluation.

UK’s Early Value Assessment Pilot Is ‘Catalyst’ For Wider Change - NICE

More from Europe

More from Geography